Topical Intranasal Anesthetic Block for Reducing the Pain of Botulinum Toxin Injections for Chronic Migraine
Part of paid clinical trials in East Providence, Rhode Island.
- Sponsor
- Association of Migraine Disorders
- Study ID
- NCT07571889
- Status
- Recruiting
Conditions
- Pain From onabotulinumtoxinA Injections
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- onabotulinumtoxinA prophylaxis with Lidocaine — PROCEDUREThe onabotulinumtoxinA prophylaxis procedure is the modified PREEMPT protocol consisting of 56 injections; 200 Units. The solution from the vial (lidocaine) will be dripped onto 2 small pieces of cotton. One piece of cotton will be placed in the anterior portion of the nasal cavity on each side of the nose. The cotton will be removed after 5 minutes. The clinician will then perform the various series of injections while assessing pain of the injection site following each series of injections.
- OnabotulinumtoxinA prophylaxis with Saline — PROCEDUREThe onabotulinumtoxinA prophylaxis procedure is the modified PREEMPT protocol consisting of 56 injections; 200 Units. The solution from the vial (Saline) will be dripped onto 2 small pieces of cotton. One piece of cotton will be placed in the anterior portion of the nasal cavity on each side of the nose. The cotton will be removed after 5 minutes. The clinician will then perform the various series of injections while assessing pain of the injection site following each series of injections.
Study Details
People find the injections used in onabotulinumtoxinA (Botox®) uncomfortable. This study will test whether putting a small piece of cotton soaked with 4% lidocaine (a numbing medicine) inside the front of each nostril for 5 minutes before the injections reduces injection pain compared with cotton soaked in saline (salt water).
Key Dates
- Start date
- Mar 3, 2026
- Status verified
- May 2026
- Primary completion
- Jan 31, 2027
- Completion
- Jan 31, 2027
Study Design
- Enrollment
- 18 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- CROSSOVER
- Primary purpose
- PREVENTION
Arms
- Experimental: LidocaineIntranasal 4% lidocaine: vial with 1ml solution with added flavor
- Placebo Comparator: SalineVial with 1ml liquid containing 0.9% sodium chloride solution with identical flavor
Primary Outcome Measure
Overall patient-reported injection pain [ Time Frame: Immediately before and immediately following the procedure at Study Visit 1 and again 12 weeks later at Study Visit 2. ]
Central Contacts
- Frederick A Godley, MD401-274-2300
- Leigh Serth
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University Otolaryngology | East Providence | Rhode Island | 02905 |
Find similar trials in East Providence, RI
By research site